en · de · es · fr · pt
ghk-cu-notes.peptides5388.com › Topic › Peptide Identity And Copper Binding — Quick Reference

Peptide Identity And Copper Binding — Quick Reference

By Editorial Desk · published 2026-07-16 · last reviewed 2026-08-01 · Topic

Everything below concerns GHK-Cu. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.

Updated 2026-08-01. Numbers and descriptions here follow the published literature rather than marketing material.

Peptide Identity and Copper Binding

GHK-Cu is a coordination complex formed between the tripeptide glycyl-L-histidyl-lysine and a copper(II) ion. The peptide sequence is conventionally written as Gly-His-Lys, abbreviated GHK. Copper binds through the imidazole nitrogen of histidine, the alpha-amino group, and a deprotonated amide nitrogen, producing a square-planar geometry. The complex carries a net positive charge near physiological pH and is intensely blue in aqueous solution. The metal-free peptide is often written simply as GHK, while the copper-bound form is written GHK-Cu.

The compound was first isolated from human plasma by the biochemist Loren Pickart in 1973. Early work identified it as a factor that altered the behavior of cultured liver cells, and later studies linked it to connective tissue and wound-related processes. Reported plasma concentrations fall markedly between roughly age twenty and age sixty, a pattern that generated interest in copper peptide biology. Whether that decline has functional consequences remains an open question, because differences observed across age groups do not by themselves establish causation. Research interest later expanded into cosmetic and tissue-culture settings.

Molecular Identity and Discovery Background

The peptide portion consists of three amino acids: glycine, histidine and lysine. Copper(II) coordinates through the imidazole nitrogen of histidine, the alpha-amino group of glycine and a deprotonated amide nitrogen of the backbone, producing a roughly square-planar geometry. This arrangement gives the complex its characteristic blue-to-violet colour and helps it resist dissociation in water. Reported stability constants are high, although values differ between studies because of differences in ionic strength and measurement method.

The International Nomenclature of Cosmetic Ingredients lists the substance as copper tripeptide-1, the name that appears on most topical product labels. Related designations include copper peptide and GHK-Cu, and the hyphenated form is common in research literature. In cosmetics the material is regulated as an ingredient rather than as a drug, so products may reach the market without evidence of the effects claimed for them. Whether those effects are clinically meaningful is an open question, since most supportive data come from laboratory work and small trials.

Ghk-cu at a glance

PropertyValueNotes
Molecular formulaC14H22CuN6O4 as the complexFree peptide is C14H24N6O4
Molecular weightAbout 402 g/molFree peptide is about 340 g/mol
AppearanceBlue solid or blue solutionColor from copper d-d transitions
Solubility classWater-soluble; poor in nonpolar solventsIonic character favors aqueous media
Common synonymsCopper tripeptide-1; glycyl-L-histidyl-L-lysine copperINCI listing uses copper tripeptide-1

Copper Tripeptide Complex Background

Published studies describe the complex in several research contexts, including collagen synthesis, antioxidant behaviour, and wound repair models. Much of this work is conducted in cultured cells or in small animal systems, and the findings are frequently cited in reviews of copper peptides. Direct clinical evidence in humans is comparatively limited, and reported outcomes vary with formulation and study design. Whether free chain or metal-bound form was used is not always stated, a point that complicates comparison between reports.

GHK-Cu is a coordination complex formed between the peptide glycyl-L-histidyl-L-lysine and a copper(II) ion. The unbound chain, abbreviated GHK, consists of three amino acids and occurs naturally in human plasma, saliva, and urine. Binding of the metal is mediated mainly by the imidazole nitrogen of the histidine residue together with backbone amides, producing a stable chelate. Ingredient nomenclature often lists the same substance as copper tripeptide-1. Its charge and solubility behaviour differ from those of the metal-free chain.

The copper-binding activity of this sequence was described in the 1970s during studies of liver tissue and plasma factors. Early work identified the peptide as a component that influenced copper uptake by cells and that appeared in wound fluid. Later investigations examined its presence across species, reporting the same chain in human and animal samples. A decline in measured concentration with age became a recurring observation, although the underlying causes remain incompletely characterised.

Related pages on this site

Molecular Identity and Discovery

The sequence carries three residues in the order glycine, histidine, lysine, which places a small, flexible chain around a single metal centre. Compared with larger copper-binding proteins, the complex is compact and its coordination chemistry can be reproduced with synthetic peptide in a laboratory. Published structural work agrees on the nitrogen donor set but differs in the exact geometry assigned under some conditions, so the arrangement is best treated as well characterised in outline rather than fixed in every detail.

GHK-Cu is a coordination complex formed between the tripeptide glycyl-L-histidyl-L-lysine and a copper(II) ion. The peptide was isolated from human plasma in the early 1970s by Loren Pickart, who observed that a plasma fraction from young donors stimulated growth in cultured liver cells. The copper-bound form is abbreviated GHK-Cu, while the metal-free peptide is written simply as GHK. In the research literature the complex also appears as copper tripeptide-1 and as glycyl-histidyl-lysine copper complex.

Reference notes

There is an ongoing opioid epidemic (also known as the opioid crisis) in the United States, originating out of both medical prescriptions and illegal sources. It has been described by doctors and researchers as "one of the most devastating public health catastrophes of our time". The opioid epidemic unfolded in three waves. The first wave of the epidemic in the United States began in the late 1990s, according to the Centers for Disease Control and Prevention (CDC), when opioids were increasingly prescribed for pain management, resulting in a rise in overall opioid use throughout subsequent years. The second wave was from an expansion in the heroin market to supply already addicted people. The third wave, starting in 2013, was marked by a steep tenfold increase in the synthetic opioid-involved death rate as synthetic opioids flooded the US market. In the United States, there were approximately 109,600 drug-overdose-related deaths in the 12-month period ending January 31, 2023, at a rate of 300 deaths per day. From 1999 to 2020, nearly 841,000 people died from drug overdoses, with prescription and illicit opioids responsible for 500,000 of those deaths. Drug overdose deaths totaled 70,237 in 2017, with 47,600 involving an opioid. This surpassed deaths from car crashes (37,133) by 28%. A December 2017 report estimated that 130 people die every day in the United States due to opioid-related drug overdose. The great majority of Americans surveyed in 2015 who used prescription opioids did not believe that they were misusing them.

The National Institutes of Health (NIH) is the primary agency of the United States federal government responsible for biomedical and public health research. It was founded in 1887 and is part of the United States Department of Health and Human Services (HHS). Many NIH facilities are located in Bethesda, Maryland, and other nearby suburbs of the Washington metropolitan area, with other primary facilities in Research Triangle Park in North Carolina and smaller satellite facilities located around the United States. The NIH conducts its scientific research through the NIH Intramural Research Program (IRP) and provides significant biomedical research funding to non-NIH research facilities through its Extramural Research Program. As of 2013, the IRP had 1,200 principal investigators and more than 4,000 postdoctoral fellows in basic, translational, and clinical research, being the largest biomedical research institution in the world, while, as of 2003, the extramural arm provided 28% of biomedical research funding spent annually in the U.S., or about US$26.4 billion. Basic research by the NIH contributed to every new drug approved by the Federal Drug Administration over the period 2010–2016. In early 2025, the Trump administration froze key NIH operations, and by January 2026 about 2,600 grants totaling $1.4 billion remained suspended, though some were reinstated due to court orders.

=== Targeting the tricarboxylic acid cycle and glutaminolysis === The tricarboxylic acid cycle (TCA) and glutaminolysis can also be targeted for cancer treatment, since they are essential for the survival and proliferation of cancer cells. Ivosidenib and enasidenib, two FDA-approved cancer treatments, can arrest the TCA cycle of cancer cells by inhibiting isocitrate dehydrogenase-1 (IDH1) and isocitrate dehydrogenase-2 (IDH2), respectively. Ivosidenib is specific to acute myeloid leukemia (AML) and cholangiocarcinoma, whereas enasidenib is specific to just acute myeloid leukemia (AML). In a clinical trial consisting of 185 adult patients with cholangiocarcinoma and an IDH-1 mutation, there was a statistically significant improvement (p<0.0001; HR: 0.37) in patients randomized to ivosidenib. Still, some of the adverse side effects in these patients included fatigue, nausea, diarrhea, decreased appetite, ascites, and anemia. In a clinical trial consisting of 199 adult patients with AML and an IDH2 mutation, 23% of patients experienced complete response (CR) or complete response with partial hematologic recovery (CRh) lasting a median of 8.2 months while on enasidenib. Of the 157 patients who required transfusion at the beginning of the trial, 34% no longer required transfusions during the 56-day time period on enasidenib. Of the 42% of patients who did not require transfusions at the beginning of the trial, 76% still did not require a transfusion by the end of the trial.

== Prevention == It is not possible to completely prevent hypertrophic scars, so those with a history of them should inform their doctor or surgeon if they need surgery. Pressure garment therapy is a commonly used approach to try to prevent hypertrophic scarring after a burn, but the effectiveness of this approach is unclear.

Sources: en.wikipedia.org

Notes from published material

=== Kyphoscoliosis === Kyphoscoliosis EDS (kEDS; formerly categorized as type 6) is associated with severe hypotonia at birth, delayed motor development, progressive scoliosis (present from birth), and scleral fragility. People may also have easy bruising, fragile arteries that are prone to rupture, unusually small corneas, and osteopenia (low bone density). Other common features include a "marfanoid habitus" characterized by long, slender fingers (arachnodactyly), unusually long limbs, and a sunken chest (pectus excavatum) or protruding chest (pectus carinatum). It can be caused by variations in the gene PLOD1, or rarely, in the FKBP14 gene.

=== Pre-release === SFM was developed internally at Valve in 2005 and most of it was based on the code from the in-game demo playback tool found in Source. SFM was used to make Day of Defeat: Source trailers with effects that could not be achieved in real-time. The tool was used extensively for certain promotional materials for the release of Team Fortress 2, particularly the Meet the Team trailers. This version of SFM, which ran using Source's in-game tools framework, was unintentionally leaked during the public beta of Team Fortress 2 in September 2007. By 2010, the entire interface was re-implemented using Qt 4 and given its engine branch for further development. Before SFM was released to the public, Team Fortress 2 carried a simplified version of SFM known as the "Replay Editor", which was limited to capturing the actual events occurring throughout a player's life. It provided no ability to modify actions, repeat segments, or apply special effects beyond those already used in-game. However, arbitrary camera angles were possible, such as tracking the movements of other players in action at the time. The Replay Editor also allowed users to upload completed videos to YouTube. On June 27, 2012, SFM became available on a limited basis through Steam, the same day the final Meet the Team video "Meet the Pyro" was released. The open beta for Windows was released as of July 11, 2012. From 2011 to 2018, Valve operated a competition known as the Saxxy Awards for community-made SFM animations.

== Contraindications == Pioglitazone/metformin is contraindicated in people with known hypersensitivity to any components of this combination. These combination also contraindicated in renal disease which may also result from conditions, e.g., acute myocardial infarction, sepsis, acute or chronic metabolic acidosis, including diabetic ketoacidosis, with or without coma.

Human (and other eukaryote) cells can produce ATP from glucose without oxygen in a process called glycolysis. This is not as efficient as respiration, but provides a high instantaneous output, and is hence used by some muscle cells. Glycolysis consumes ADP, Pi, glucose, and NAD+ to produce ATP, pyruvate, and NADH. Through lactate fermentation, pyruvate and NADH are turned into lactate and NAD+, thereby regenerating the NAD+ required for more glycolysis. During the 1990s, the lactic acid hypothesis was created to explain why people experienced burning or muscle cramps that occurred during and after intense exercise. The hypothesis proposes that a lack of oxygen in muscle cells results in a switch from cellular respiration to fermentation. Lactic acid created as a byproduct of fermentation of pyruvate from glycolysis accumulates in muscles causing a burning sensation and cramps. Research from 2006 has suggested that acidosis isn't the main cause of muscle cramps. Instead cramps may be due to a lack of potassium in muscles, leading to contractions under high stress. Animals, in fact, do not produce lactic acid during fermentation. Despite the common use of the term lactic acid in the literature, the byproduct of fermentation in animal cells is lactate. Another change to the lactic acid hypothesis is that when sodium lactate is inside of the body, there is a higher period of exhaustion in the host after a period of exercise.

=== Affinity Chromatography === Affinity chromatography exploits the specific interactions between proteins and their ligands. A target protein is captured on a column containing a ligand that specifically binds to it, such as an antibody, enzyme substrate, or metal ion. After washing away non-specifically bound proteins, the target protein is eluted using a solution that disrupts the protein-ligand interaction. This method provides high specificity and is often used for purifying recombinant proteins that have affinity tags.

Sources: en.wikipedia.org

Further detail

=== The position of turtles === The placement of turtles has historically been highly variable. Classically, turtles were considered to be related to the primitive anapsid reptiles. In their comparative analysis of the timing of organogenesis, Werneburg and Sánchez-Villagra (2009) found support for the hypothesis that turtles belong to a separate clade within Sauropsida, outside the saurian clade altogether. Molecular work has usually placed turtles within the diapsids. As of 2013, three turtle genomes have been sequenced. The results place turtles as a sister clade to the archosaurs, the group that includes crocodilians, non-avian dinosaurs, and birds. A 2026 study found that they were nested within Archosauromorpha, with strong morphological support.

Any individual member of the clinical trial team designated and supervised by the investigator at a trial site to perform critical trial-related procedures and/or to make important trial-related decisions (e.g., associates, residents, research fellows). (ICH E6) Subject Identification Code

The following day, it was reported that Paetongtarn informed the Move Forward Party leaders that Pheu Thai Party needed to bring the Palang Pracharath Party, led by General Prawit Wongsuwan, into the coalition government. This led to the Move Forward Party deciding, six days later, not to support Pheu Thai's prime ministerial candidate. Following weeks of debate, Srettha was elected prime minister by the parliament of Thailand. On 13 September 2023, during the first meeting of the 63rd Thai Cabinet, Prime Minister Srettha Thavisin ordered the establishment of the National Soft Power Strategy Committee and appointed Paetongtarn as the Deputy Chairperson. Later, on 3 October, Srettha appointed her to two additional positions: Chairperson of the National Soft Power Development Committee and a member of the Committee for the Organization of Celebrations for King Vajiralongkorn's 72nd Birthday Anniversary on 28 July 2024. Subsequently, on 7 October, Srettha appointed her as the Deputy Chairperson of the National Health System Development Committee. On 27 October 2023, Paetongtarn was elected by the PTP's core members during a general assembly held at the party's head office to become the party's new leader, receiving 289 votes with one abstention.

== Functions of aquatic plants == One of the largest aquatic plants in the world is the Bolivian waterlily, which holds the Guinness World Record of having the largest undivided leaf at 3.2 m (10 ft 6 in) diameter; the smallest is the rootless duckweed, which is only 1 mm (0.039 in) across. Many small animals use aquatic plants such as duckweeds and lily pads for spawning or as protective shelters against predators both from above and below the water surface. Aquatic plants are important primary producers and are the basis of food web for many aquatic fauna, especially wetland species. They compete with phytoplanktons for excess nutrients such as nitrogen and phosphorus, thus reducing the prevalence of eutrophication and harmful algal blooms, and have a significant effect on riparian soil chemistry as their leaves, stems and roots slow down the water flow, capture sediments and trap pollutants. Excess sediment will settle into the stream bed due to the reduced flow rates, and some aquatic plants also have symbiotic microbes capable of nitrogen fixation and breaking down the pollutants trapped and/or absorbed by the roots. Historically, aquatic plants have been less studied than terrestrial plants, and management of aquatic vegetation has become an increasingly interested field as means to reduce agricultural pollution of water bodies.

Sources: en.wikipedia.org

Frequently asked questions

What is GHK-Cu chemically?

It is the copper(II) complex of the tripeptide glycyl-L-histidyl-lysine, a sequence of three amino acids. The copper ion is held by the histidine imidazole, the terminal amino group, and an amide nitrogen. The bound form is distinct from the free peptide in charge, color, and stability.

Why is the complex blue?

Copper(II) complexes absorb light in the red part of the visible spectrum, so transmitted light appears blue. The absorption arises from electronic transitions within the copper d-orbitals, which are split by the surrounding ligands. The intensity and exact wavelength shift somewhat with pH, solvent, and ligand arrangement.

Is the peptide active without copper?

The free peptide and the copper-bound complex are studied as separate species and do not always behave the same way in assays. Some reported responses are attributed to copper delivery, while others are attributed to the peptide sequence itself. Which fraction drives a given observation is often unresolved in the published work.

What is GHK-Cu made of?

It is a complex of a three-amino-acid peptide, glycine, histidine and lysine, bound to a single copper(II) ion. The metal is held mainly by the histidine side chain and the peptide backbone. Most commercial material is supplied as an acetate salt rather than as the free complex.

Network